Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of organic pyrophosphates and is known as an experimental drug with no established clinical use in humans. It has been studied primarily as a ligand or inhibitor for biochemical research purposes rather than as a therapeutic agent. Its main identified biological target is acetolactate synthase (catabolic), specifically from the bacterium Klebsiella pneumoniae; however, its pharmacological action in humans remains unknown and it does not have an approved medical indication[2][6]. The compound's structure features a pyrimido-thiazolo-pyrimidine core with ethyl trihydrogen diphosphate substitution.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-d][1,3]thiazolo[3,2-a]pyrimidin-8-yl}ethyl trihydrogen diphosphate.